Profits are soaring, resignations are shaking up markets, and drug trials are rewriting the leaderboard. Join Michelle Martin on her tour of markets! Goldman Sachs smashes expectations with a $4.7B quarter as trading volatility fuels the Street. Hotel Properties surges on Ong Beng Seng’s exit, and Pfizer’s setback boosts rivals in the weight-loss race. Hosted by Michelle Martin with Ryan Huang, this episode also tracks Wilmar, Apple, Intel, Olam, Goldman Sachs, JPMorgan Chase, Morgan Stanley, Hotel Properties (HPL), Wilmar International, Novo Nordisk, Eli Lilly, Pfizer, Structure Therapeutics, Metsera, Intel, Apple, Olam Group, Singapore Exchange (SGX), Sembcorp Industries.See omnystudio.com/listener for privacy information.

Profits are soaring, resignations are shaking up markets, and drug trials are rewriting the leaderboard. Join Michelle Martin on her tour of markets! Goldman Sachs smashes expectations with a $4.7B quarter as trading volatility fuels the Street. Hotel Properties surges on Ong Beng Seng&rsquo;s exit, and Pfizer&rsquo;s setback boosts rivals in the weight-loss race. Hosted by Michelle Martin with Ryan Huang, this episode also tracks Wilmar, Apple, Intel, Olam, Goldman Sachs, JPMorgan Chase, Morgan Stanley, Hotel Properties (HPL), Wilmar International, Novo Nordisk, Eli Lilly, Pfizer, Structure Therapeutics, Metsera, Intel, Apple, Olam Group, Singapore Exchange (SGX), Sembcorp Industries.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Market View: Big Bank Windfalls, Property Power Plays & Pharma Winners from Pfizer setback